Prognostic value of perfusion-weighted imaging in brain glioma: A prospective study

Acta Neurochirurgica

Volumn 148, Issue 3, 2006, Pages 277-285

  Chaskis, C ^a   Stadnik, T ^a   Michotte, A ^a   Van Rompaey, K ^a   D'Haens, J ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Glioma; Perfusion imaging; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; BRAIN REGION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOTOMY; DISEASE SEVERITY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; BIOPSY; BRAIN; BRAIN MAPPING; BRAIN NEOPLASMS; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; CHILD; DIAGNOSTIC ERRORS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES;

EID: 33644787354     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-005-0718-9     Document Type: Article

References (49)

1. HJ Aronen IE Gazit DN Louis BR Buchbinder FS Pardo RM Weisskoff GR Harsh GR Cosgrove EF Halpern FH Hochberg 1994 Cerebral blood volume maps of gliomas: comparison with tumour grade and histologic findings. Radiology 191 41 51
2. HJ Aronen J Glass FS Pardo JW Belliveau ML Gruber BR Buchbinder IE Gazit RM Linggood AJ Fischman BR Rosen 1995 Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 36 520 528
3. S Asari T Makabe S Katayama T Itoh S Tsuchida T Ohmoto 1994 Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology 36 308 310
4. FG Barker 2nd SM Chang SL Huhn RL Davis PH Gutin MW [tmp] McDermott CB Wilson MD Prados 1997 Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80 936 941
5. A Batra RP Tripathi AK Singh 2004 Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging. Australasian Radiology 48 324 332
6. F Benard J Romsa R Hustinx 2003 Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 33 2 148 162
7. S Brem R Cotran J Folkman 1972 Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48 347 356
8. R Bruening KK Kwong MJ Vevea 1996 Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. AJNR 17 831 840
9. BL Dean BP Drayer CR Bird 1990 Gliomas Classification with MR imaging. Radiology 174 411 415
10. G Di Chiro RL De LaPaz RA Brooks L Sokoloff PL Kornblith BH Smith NJ Patronas CV Kufta RM Kessler GS Johnston RG Manning AP Wolf 1982 Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32 1323 1329
11. KN Fountas EZ Kapsalaki RL Vogel I Fezoulidis JS Robinson ED Gotsis 2004 Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 92 90 97
12. LE Ginsberg GN Fuller M Hashmi NE Leeds DF Schomer 1998 The Significance of Lack of MR Contrast Enhancement of Supratentorial Brain Tumors in Adults: Histopathological Evaluation of a Series. Surg Neurol 49 436 440
13. RG Henry DB Vigneron NJ Fischbein PE Grant MR Day SM Noworolski JM Star-Lack LL Wald WP Dillon SM Chang SJ Nelson 2000 Comparison of Relative Cerebral Blood Volume and Proton Spectroscopy in Patients with Treated Gliomas. AJNR 21 357 366
14. A Jackson A Kassner D Annesley-Williams H Reid X-P Zhu K-L Li 2002 Abnormalities in the Recirculation Phase of Contrast Agent Bolus Passage in Cerebral Gliomas: comparison with Relative Blood Volume and Tumor Grade. AJNR 23 7 14
15. Kleihues P, Cavenee WK (eds) (2000) World Health Organisation classification of tumours: pathology and genetics of tumours of the nervous system. IARC Press, Lyon
16. EA Knopp S Cha G Johnson A Mazumdar JG Golfinos D Zagzag DC Miller PJ Kelly II Kricheff 1999 Glial neoplasms: dynamic contrast-enhanced T2-weighted MR imaging. Radiology 211 791 798
17. D Kondziolka LD Lunsford AJ Martinez 1993 Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79 533 536
18. S Kremer S Grand C Remy F Esteve V Lefournier B Pasquier D Hoffmann AL Benabid JF Le Bas 2002 Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 29 105 113
19. YE Kuznetzov Z Caramanos SB Antel MC Preul R Leblanc JG Villemure R Pokrupa A Olivier A Sadikot DL Arnold 2003 Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas. Neurosurgery 53 565 574
20. M Law S Yang JS Babb EA Knopp JG Golfinos D Zagzag G Johnson 2004 Comparison of Cerebral Blood Volume and Vascular Permeability from Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade. AJNR 25 746 755
21. M Law S Yang H Wang JS Babb G Johnson S Cha EA Knopp D Zagzag 2003 Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24 10 1989 1998
22. V Lefournier M Peoc'h Y Usson JL Bosson S Grand B Pasquier JF Le Bas 2003 Magnetic resonance cerebral blood volume maps. Comparison with histologic findings in different types of brain lesions. J Neuroradiol 30 3 9
23. SP Leon RD Folkerth PM Black 1996 Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77 362 372
24. MH Lev Y Ozsunar JW Henson AA Rasheed GD Barest Harsh GR 4th MM Fitzek EA Chiocca JD Rabinov AN Csavoy BR Rosen FH Hochberg PW Schaefer RG Gonzalez 2004 Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR 25 214 221
25. L Ludemann W Grieger R Wurm M Budzisch B Hamm C Zimmer 2001 Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 11 1231 1241
26. M Maeda S Itoh H Kimura T Iwasaki N Hayashi K Yamamoto Y Ishii T Kubota 1993 Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 189 233 238
27. ACM Maia Jr SMF Malheiros AJ Da Rocha JN Stavale IF Guimaraes LRR Borges AJ Santos CJ Da Silva JGSP De Melo OP Lanzoni AA Gabbai FAP Ferraz 2004 Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. J Neurosurg 101 970 976
28. C Majos J Alonso C Aguilera M Serrallonga J Perez-Martin JJ Acebes C Arus J Gili 2003 Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol 13 3 582 591
29. WH Martin D Delbeke JA Patton 1996 Detection of malignancies with SPECT versus PET, with 2-[fluorine-18] fluoro-2-deoxy-D-glucose. Radiology 198 225 231
30. T Naëgele D Petersen U Klose 1993 Dynamic contrast enhancement of intracranial tumors with snapshot-FLASH MR imaging. AJNR 14 89 98
31. R Nafe S Herminghaus U Pilatus E Hattingen G Marquardt W Scholte H Lanfermann F Zanella 2004 Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy. Neuropathology 24 172 182
32. T Ogawa A Inugami J Hatazawa 1996 Clinical positron emission tomography for brain tumors: comparison of fluorodeoxyglucose F18 and L-methyl C-methionone. AJNR Am J Neuroradiol 17 345 353
33. J Oh RG Henry A Pirzkall Y Lu X Li I Catalaa S Chang WP Dillon SJ Nelson 2004 Survival analysis in patients with glioblastoma multiforme: predictive value of Choline-to-N-Acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 19 546 554
34. MV Padma S Said M Jacobs DR Hwang K Dunigan M Satter B Christian J Ruppert T Bernstein G Kraus JC Mantil 2003 Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 64 3 227 237
35. J Perkio HJ Aronen A Kangasmaki Y Liu J Karonen S Savolainen L Ostergaard 2002 Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med 47 973 981
36. M Plotkin J Eisenacher H Bruhn R Wurm R Michel F Stockhammer A Feussner O Dudeck P Wust R Felix H Amthauer 2004 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 70 49 58
37. C Preul B Kühn EW Lang HM Mehdorn M Heller J Link 2003 Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging European. J Radiology 48 244 251
38. JM Provenzale GR Wang T Brenner JR Petrella AG Sorensen 2002 Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 178 3 711 716
39. J Pruim AT Willemsen WM Molenaar 1995 Brain tumors: L-[1-C-11] tyrosine PET for visualization and quantification of protein synthesis rate. Radiology 197 221 226
40. HC Roberts TP Roberts RC Brasch WP Dillon 2000 Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21 891 899
41. BR Rosen JW Belliveau JM Vevea 1990 Perfusion imaging with NMR contrast agents. Magn Reson Med 14 249 265
42. M Sasaki Y Kuwabara T Yoshida M Nakagawa T Fukumura F Mihara T Morioka M Fukui K Masuda 1998 A comparative study of thallium-201 SPECT, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 25 9 1261 1269
43. JH Shin HK Lee BD Kwun JS Kim W Kang CG Choi DC Suh 2002 Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR 179 3 783 789
44. T Siegal R Rubinstein T Tzuk-Shina JM Gomori 1997 Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 86 22 27
45. T Sugahara Y Korogi M Kochi I Ikushima T Hirai T Okuda Y Shigematsu L Liang Y Ge Y Ushio M Takahashi 1998 Correlation of MR Imaging-Determined Cerebral Blood Volume Maps with Histologic and Angiographic Determination of Vascularity of Gliomas. AJR 171 1479 1486
46. M Tamura T Shibasaki A Zama H Kurihara S Horikoshi N Ono N Oriuchi T Hirano 1998 Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride. Neuroradiology 40 4 210 215
47. G Tedeschi N Lundbom R Raman S Bonavita JH Duyn JR Alger G Di Chiro 1997 Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87 4 516 524
48. M Watanabe R Tanaka N Takeda 1992 Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34 463 469
49. D Yang Y Korogi T Sugahara M Kitajima Y Shigematsu L Liang Y Ushio M Takahashi 2002 Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44 656 666